What is the current valuation of the US Alzheimer's disease-diagnostic market?

The market valuation was $2800.0 Million in 2024. Read More

What is the projected market size for the US Alzheimer's disease-diagnostic market by 2035?

The market is expected to reach $7250.0 Million by 2035. Read More

What is the expected CAGR for the US Alzheimer's disease-diagnostic market during the forecast period 2025 - 2035?

The expected CAGR is 9.03% during the forecast period. Read More

Which companies are the key players in the US Alzheimer's disease-diagnostic market?

Key players include Eli Lilly and Company, Biogen Inc., Roche Holding AG, Novartis AG, AstraZeneca PLC, Merck & Co., Inc., Johnson & Johnson, and AbbVie Inc. Read More

What are the main segments of the US Alzheimer's disease-diagnostic market?

The main segments include Type, Diagnostic Tests, and End User. Read More

What was the market valuation for Early Onset Alzheimer's in 2024?

The market valuation for Early Onset Alzheimer's was $280.0 Million in 2024. Read More

How much is the Late Onset Alzheimer's segment projected to grow by 2035?

The Late Onset Alzheimer's segment is projected to grow to $2100.0 Million by 2035. Read More

What is the valuation range for Brain Imaging as a diagnostic test?

The valuation range for Brain Imaging is $1120.0 Million to $2800.0 Million. Read More

Which end user segment had a valuation of $840.0 Million in 2024?

The Hospital end user segment had a valuation of $840.0 Million in 2024. Read More

What is the projected valuation for Genetic Testing by 2035?

The projected valuation for Genetic Testing is expected to reach $725.0 Million by 2035. Read More

US Alzheimers Disease Diagnostic Market

US Alzheimer's Disease Diagnostic Market Research Report: Size, Share, Trend Analysis By Types (Early Onset Alzheimers, Late Onset Alzheimers, Familial Alzheimers Disease, Others), By Diagnostic Tests (Genetic Testing, Neurological Exam, Mini Mental State Exam (MMSE), Brain Imaging, Others) and By End Users (Clinic, Hospital, Diagnostic Center, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

9.03%

2024 Market Size

$ 2,800 Million

2035 Market Size

$ 7,250 Million

Medical Device ● Updated August 2026 Report ID: MRFR/MED/14705-HCR | Pages: 100 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  1. 4.1.1 Early Onset Alzheimers
  2. 4.1.2 Late Onset Alzheimers
  3. 4.1.3 Familial Alzheimers Disease
  4. 4.1.4 Others
2. 4.2 Food, Beverages & Nutrition, BY Diagnostic Tests (USD Million)
  1. 4.2.1 Genetic Testing
  2. 4.2.2 Neurological Exam
  3. 4.2.3 Mini Mental State Exam (MMSE)
  4. 4.2.4 Brain Imaging
  5. 4.2.5 Others
3. 4.3 Food, Beverages & Nutrition, BY End User (USD Million)
  1. 4.3.1 Clinic
  2. 4.3.2 Hospital
  3. 4.3.3 Diagnostic Center
  4. 4.3.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Eli Lilly and Company (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Biogen Inc. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche Holding AG (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Novartis AG (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 AstraZeneca PLC (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Merck & Co., Inc. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Johnson & Johnson (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AbbVie Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY DIAGNOSTIC TESTS
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
8. 6.8 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
9. 6.9 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
11. 6.11 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSTIC TESTS, 2024 (% SHARE)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY DIAGNOSTIC TESTS, 2024 TO 2035 (USD Million)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSTIC TESTS, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Alzheimers Disease Diagnostic Market Segmentation

US Alzheimers Disease Diagnostic Market By Type (USD Million, 2025-2035)

Early Onset Alzheimers
Late Onset Alzheimers
Familial Alzheimers Disease
Others

US Alzheimers Disease Diagnostic Market By Diagnostic Tests (USD Million, 2025-2035)

Genetic Testing
Neurological Exam
Mini Mental State Exam (MMSE)
Brain Imaging
Others

US Alzheimers Disease Diagnostic Market By End User (USD Million, 2025-2035)

Clinic
Hospital
Diagnostic Center
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”